The IPO List
HomeListingsBlogsAboutJoin WhatsApp CommunityWhatsApp(Opens in a new tab)

The IPO List

Your trusted platform for IPO tracking and investment insights.

Quick Links

IPOsIPO ArchiveBlogsGMP AccuracyMethodologyAboutContact

Legal

Privacy PolicyTerms of ServiceDisclaimer

© 2026 The IPO List. All rights reserved.

  1. Home/
  2. IPO Calendar/
  3. Rubicon Research IPO
Rubicon Research
MainboardListed

Rubicon Research IPO

Bidding 9-13 Oct 2025, price band ₹461–485, lot 30 shares.

OverviewGMPAllotment

Grey Market Premium Trend

₹120
Final GMP
₹605
GMP-Implied Listing Price
24.7%
GMP-Implied Gain
₹461 - ₹485
Price Band

GMP History

DateGMP (₹)Est. Listing Price (₹)Est. Listing Gain
15 Oct₹120₹60524.74%
14 Oct₹151₹63631.13%
13 Oct₹128₹61326.39%
12 Oct₹127₹61226.19%
11 Oct₹96₹58119.79%
10 Oct₹110₹59522.68%
9 Oct₹111₹59622.89%
8 Oct₹100₹58520.62%
7 Oct₹98₹58320.21%
6 Oct₹80₹56516.49%
5 Oct₹80₹56516.49%
4 Oct₹68₹55314.02%
3 Oct₹60₹54512.37%
2 Oct₹0₹4850.00%
1 Oct₹0₹4850.00%

IPO timeline

  1. Issue open date
    9 Oct 2025
  2. Issue close date
    13 Oct 2025
  3. UPI mandate deadline
    13 Oct 2025
  4. Allotment finalization
    14 Oct 2025
  5. Refund initiation
    15 Oct 2025
  6. Share credit
    15 Oct 2025
  7. Listing date
    16 Oct 2025
  8. Mandate end date
    28 Oct 2025
  9. Lock-in end date for anchor investors (50%)
    13 Nov 2025
  10. Lock-in end date for anchor investors (remaining)
    12 Jan 2026

Rubicon Research IPO Allotment Status

Allotment date:14 Oct 2025
Registrar:MUFG Intime India Private Limited - Link Intime
  1. Open the registrar's allotment page from the link below.
  2. Select Rubicon Research from the list of companies.
  3. Enter your PAN, application number or demat account (DP/Client ID).
  4. Submit to see how many shares you were allotted.
Check allotment on MUFG Intime India(Opens in a new tab)BSE application status check(Opens in a new tab)

After allotment

Refund / mandate release:15 Oct 2025
Shares credited to demat:15 Oct 2025
Listing:16 Oct 2025
💸

IPO Subscription Status

CategoryTimesEst. Allotment Chances*
HNIs (Total)102.66🔥0.97%
bHNI117.77🔥0.85%
sHNI72.43🔥1.4%
QIBs137.09🔥-
Retail36.82🔥2.7%
Employees17.49🔥5.7%

*Rough estimate: 1 ÷ times subscribed. Retail and HNI allotment is by lottery, so actual odds depend on the number of applications.

Last updated: 13 October'25 04:44PM

Quick Stats

Issue Size:1378cr
Lot Size:30 shares
Min Investment:₹14,550
P/E Ratio:55.75

About the Company

Rubicon Research Limited, established in 1999, is a pharmaceutical formulation company focused on innovation through research and development, with a strong presence in regulated markets, particularly the United States.The company operates two R&D facilities inspected by the USFDA (United States Food and Drug Administration) in India and Canada, along with two manufacturing plants in India. It holds accreditations from global regulatory bodies like the USFDA, WHO-GMP (World Health Organization – Good Manufacturing Practices), and Health Canada. Rubicon’s portfolio includes 55 commercialized formulations in the U.S., highlighting its focus on regulated markets.

Strengths

  • Holds a strong portfolio of commercialised products, maintaining a market share of over 25% for seven products in the US market.
  • R&D capabilities in India and Canada enable product innovation and development, reducing reliance on third parties.
  • Established US sales and distribution platform through subsidiaries, covering both non-branded and branded product markets.
  • Demonstrates regulatory compliance with US FDA inspections and approvals from international bodies.

Risks

  • The company heavily relies on the US market, making it vulnerable to adverse developments in that region.
  • Operating in a highly regulated industry, any product recalls, inspection failures, or facility shutdowns could negatively impact operations.
  • R&D efforts may not always lead to successful marketable products, posing risks to revenue growth.
  • Intense competition within the pharmaceutical industry may affect margins and hinder future growth prospects.
  • Fluctuations in foreign currency exchange rates could negatively impact the company’s financial performance.
  • Debt agreements, including unsecured loans, impose restrictive covenants, and any non-compliance could lead to accelerated repayment obligations.

Rubicon Research IPO – Frequently Asked Questions

  • The price band for the Rubicon Research IPO is set at ₹461 to ₹485 per share.
  • The Rubicon Research IPO opens on October 9, 2025 and closes on October 13, 2025.
  • The tentative listing date for the Rubicon Research IPO is October 16, 2025.
  • The last recorded Grey Market Premium (GMP) for the Rubicon Research IPO before listing was ₹120 (24.74%). GMP is unofficial and is not a guarantee of the listing price.
  • The Rubicon Research IPO allotment date is October 14, 2025. Once it is finalised, check your status with your PAN or application number on the website of the registrar, MUFG Intime India Private Limited - Link Intime. Issues listed on BSE can also be checked on the BSE application status page.
  • You can apply for the Rubicon Research IPO via your broker or bank using ASBA or UPI. Log in to your trading app (Zerodha, Upstox, Groww, etc.), select IPO section, choose Rubicon Research, enter lot quantity and UPI ID, then approve the mandate.
  • The lot size for the Rubicon Research IPO is 30 shares. Investors must apply for at least one lot (i.e., 30 shares), which costs ₹14,550 at the upper price band.

Related IPOs

Open and upcoming

  • Friends Union for Energising Lives (FUEL)Bidding 11-20 Nov 2026
    Open
  • Crystal Crop ProtectionBidding 18-20 Nov 2026
    Open
  • Mahanadi CoalfieldsBidding 19-23 Nov 2026
    Upcoming
  • Watrana RentalsBidding 19-23 Nov 2026
    Upcoming

Recent mainboard listings

  • Bombay Coated & Special SteelsListed 5 Nov 2026
    +10.98%
  • M.K.Sons Fine JewelsListed 4 Nov 2026
    +5.56%
  • BLS PolymersListed 3 Nov 2026
    +65.33%
  • SFC Environmental TechnologiesListed 3 Nov 2026
    +7.61%
  • EAAA India AlternativesListed 2 Nov 2026
    +0.63%
  • Jio PlatformsListed 28 Oct 2026
    +21.36%

All IPOs that opened in October 2025